Comment on: Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model

J Antimicrob Chemother. 2015 Feb;70(2):633. doi: 10.1093/jac/dku330. Epub 2014 Aug 23.

Authors

David W Denning¹, Nesrin Ghnan², Richard Kwizera², Ali Osmanov²

Affiliations

¹ Faculty of Medical and Health Sciences, University of Manchester, Manchester, UK National Aspergillosis Centre, University Hospital of South Manchester, Manchester, UK ddenning@manchester.ac.uk.
² Faculty of Medical and Health Sciences, University of Manchester, Manchester, UK.

PMID: 25151206
DOI: 10.1093/jac/dku330

No abstract available

Keywords: A. fumigatus; fungicidal; paediatrics.

Publication types

Letter
Comment

MeSH terms

Animals
Antifungal Agents / pharmacology*
Aspergillosis / drug therapy*
Aspergillus fumigatus / drug effects*
Humans
Voriconazole / pharmacology*

Substances

Antifungal Agents
Voriconazole